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Big questions have emerged from the beginnings of a genomic revolution that is still picking up 
steam. Completed in 2003, the Human Genome Project identified and mapped roughly 20,000 
protein coding genes composing the human 'exome', which is encoded by little more than 1% of our 
entire genome. This raised the obvious question: How much of the remaining 99% is useless 'junk' 
DNA versus functional elements of a 'regulome' that orchestrates gene regulation? Genome-wide 
association studies have found that the human exome contains only one in ten single nucleotide 
polymorphisms (SNPs) associated with the risk of various disease states. How do the remaining 
nine in ten SNPs underlie disease? A burst of new answers to these fundamental questions have 
recently been provided by the Encyclopedia of DNA Elements (ENCODE) project, to which Human 
Biology Division scientists Dr. Muneesh Tewari and Dr. Kavita Garg contributed their talents and 
expertise in predicting promoters of microRNAs, important regulators of gene expression whose own 
regulation is poorly characterized. 
After completion of a pilot phase that began in 2003, the National Human Genome Research 
Institute of NIH awarded $80 million to ENCODE consortium scientists in 2007 to better understand 
how DNA is differentially packaged and regulated in more than 150 human cell lines. As illustrated in 
the accompanying figure, the 24 standard experimental approaches of ENCODE include: assays for 
DNaseI hypersensitivity, ENCODE’s workhorse technique; next generation sequencing of 
transcribed RNA (RNAseq); assays of DNA methylation patterns; and sequencing of tiny genomic 
fragments bound to modified histones or specific transcription factors, as found by chromatin 
immunoprecipitation (ChIPseq). On September 6
th
, 2012, the findings of this massive effort were 
presented in a set of 30 papers simultaneously appearing in Nature, Genome Biology and Genome 
Research. 
The publication to which Drs. Tewari and Garg contributed was directed by ENCODE group leader 
Dr. John Stamatoyannopoulos (Department of Genome Sciences, University of Washington) and 
first-authored by Dr. Robert Thurman (Senior Scientist in the Stamatoyannopoulos Lab). This 
particular piece of the ENCODE project aimed to construct genome-wide maps of active regulatory 
regions in 125 different cell types by identifying their telltale signatures of DNaseI hypersensitive 
sites (DHSs), which have guided the discovery of all types of cis-regulatory elements including 
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promoters, enhancers, silencers and locus control regions. The resulting cell-specific maps 
contained nearly 3 million noncoding sites exposed to regulatory factors, including almost all 
previously identifiedcis-regulatory sequences and a vast landscape of new elements, most of which 
are highly specific to different cell types. 
Thurman et al. were able to annotate DHSs into categories such as repeat DHSs or DHSs 
corresponding to promoters of protein-coding genes, but they also detected numerous DHSs far 
from any protein-coding genes. The authors suspected that some of these remote DHSs might 
correspond to promoters for microRNAs. Given the prior success of the Tewari Lab in predicting 
promoters of microRNAs which are overexpressed in ovarian carcinoma (Knouf et al., 2011), the 
ENCODE group turned to Drs. Tewari and Garg for help in identifying transcription start sites (TSS) 
for all known human microRNAs. Of the 329 such TSS that were identified, 300 were found to be 
less than 500 base pairs (bp) from a DHS. Thurman et al. also found that some microRNA 
promoters resided in the accessible chromatin compartments of only a few cell types whereas others 
were localized in the accessible compartments of nearly all cell types and, thus, appeared to be 
constitutively active (see Fig. 1c of the original NatureArticle). These important contributions from the 
Tewari Lab helped Thurman et al. annotate DHSs into a category for microRNA promoters, as well 
as a category for distal DHSs not associated with microRNAs or protein-coding genes (i.e., 
intergenic DHSs located at least 10,000 bp away from a TSS). 
In addition to providing spatially precise maps of all categories of accessible chromatin in numerous 
cell types, Thurman et al.demonstrate that the binding of key transcription factors in place of 
canonical nucleosomes largely drives chromatin accessibility. Their work similarly advances our 
understanding of the connection between DNA methylation and DNA accessibility. Moreover, the 
authors link over 500,000 distal DHSs (i.e., candidate enhancers) to the promoters with which they 
become synchronously hypersensitive to DNaseI, and they demonstrate elevated mutation rates in 
the accessible chromatin compartment of cells with high proliferative potential, such as malignant 
cancer cells. 
The findings of Thurman and his many co-authors, together with reports from other ENCODE 
consortium groups, bring us closer to solving a major conundrum facing genetics: How can the 
enormous phenotypic differences seen between humans and chimpanzees be encoded by 
nucleotide differences comprising a mere 1.2% of our genome? Although divergence in protein-
coding genes is clearly a part of the solution to this mystery, new results from the ENCODE 
consortium suggest that the answer will also largely involve the combinatorial power of the regulome 
for economically orchestrating profound differences in cell fate and organismal phenotype. 
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Overview of the Encyclopedia of DNA Elements 
(ENCODE) project. (A) Genomic elements that 
are the targets of the ENCODE project (dashed 
arrows) and some of the methods (gray 
rounded boxes) used to quantify them in more 
than 150 human cell lines. (B) Summary of 
ENCODE’s workflow. To gain access to human 
ENCODE data, navigate to the UCSC Genome 
Browser, select the February 2009 assembly, 
and jump to your genomic region of interest. 
ENCODE data can be found in the 'Expression 
and Regulation' and the 'Mapping, Genes, and 
Variation' track groups. 
